Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

NCT03754790

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Phoenix Childrens Hospital Site Number : 8400009 Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Site Number : 8400019 Los Angeles, California, United States
  • Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 Orange, California, United States
  • Nemours Children's Clinic Site Number : 8400008 Jacksonville, Florida, United States
View all 79 locations
View Trial Details
Active, Not Recruiting

BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease

NCT05456880

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

NCT06449586

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • Tongji Hospital of Huazhong University of Science and Technology, Wuhan Wuhan, Hubei, China
  • Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China
  • The First Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China
View Trial Details
Active, Not Recruiting

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

NCT03330691

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

NCT04270409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCLA Site Number : 8400010 Los Angeles, California, United States
  • Colorado Blood Cancer Institute Site Number : 8400007 Denver, Colorado, United States
  • Cancer Specialist of North Florida Site Number : 8400011 Jacksonville, Florida, United States
  • University of Miami Site Number : 8400012 Miami, Florida, United States
View all 105 locations
View Trial Details
Active, Not Recruiting

French Registry of First-line Treatment of Acute Promyelocytic Leukemia

NCT02938858

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • Groupe Hospitalier SUD Amiens, France
  • Centre Hospitalier V. Dupouy Argenteuil, France
  • Hôpital Jean Minjoz Besançon, France
View all 27 locations
View Trial Details

Related conditions